UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM

描述(由申请人提供)：北卡罗来纳州社区临床肿瘤学项目(UC-CCOP)通过28年来参与国家癌症研究所的项目，在社区癌症护理方面赢得了全国声誉。UC-CCOP是自1983年以来一直得到持续资助的27个CCOP之一。UC-CCOP旨在满足社区对有前景的治疗和治疗方式以及癌症控制和预防研究的新颖和相关研究的需求。UC-CCOP的持续使命是确保该地区每一个接受服务的人都有机会参加全国性的癌症预防和/或治疗临床试验。UC-CCOP致力于提供有关癌症和所有NCI临床试验计划的教育。该赠款申请包含并定义了UC-CCOP不断扩展的愿景的明确目标。这一赠款周期的目标：增加NCI和CCOP研究基地赞助的癌症治疗、预防和控制临床试验的患者收益。通过与NCI的持续合作和拟议的战略举措，增加来自代表性不足人群的临床试验参与者的数量。与参与的研究基地和NCI合作并建立伙伴关系，增加生物谱系/转化性临床试验的组合。扩大生存期临床试验的可获得性。维护高质量的数据管理。通过基础设施和流程开发提高早期试验参与度。实现上述目标的主要战略包括(1)扩大“多学科方法”，以促进UC-CCOP和吉布斯癌症中心患者导航员计划，以确定患者导航员在临床试验收益和临床试验成功完成方面的潜在作用和有益影响；(2)与NCI合作，成为一个试点网站，以提高翻译能力 (3)利用我们的少数群体和外联导航员加强和进一步发展与社区组织的伙伴关系。

DESCRIPTION (provided by applicant): The Upstate Carolina Community Clinical Oncology Program (UC-CCOP) has achieved a national reputation for excellence in community cancer care through its 28-year participation in programs of the National Cancer Institute. The UC-CCOP is one of 27 CCOPs that have been continuously funded since 1983. The UC-CCOP seeks to meet the community's need for novel and relevant studies of promising therapeutic and treatment modalities and cancer control and prevention research. The ongoing mission of the UC-CCOP is to assure that every person in the region served is provided an opportunity for participation in a national cancer prevention and/or treatment clinical trial. UC-CCOP strives to provide education about cancer and all NCI clinical trials programs. This grant application encompasses and defines clear objectives of an ever-expanding vision for the UC-CCOP. Goals for this grant cycle:  Increase patient accrual to cancer treatment, prevention and control clinicl trials sponsored by the NCI and CCOP research bases.  Increase the number of clinical trial participants from underrepresented populations through continued collaboration with the NCI and proposed strategic initiatives.  Increase the portfolio of biospecimen/translational clinical trials in collaboration and partnership with participating research bases and the NCI.  Expand availability of survivorship clinical trials.  Maintain high-quality data management.  Improve early phase trial participation through infrastructure and process development. Key strategies to achieving the above goals include (1) expanding the "multidisciplinary approach" to foster the UC-CCOP and Gibbs Cancer Center patient navigator program in order to determine the patient navigator's potential role in and beneficial effects on clinical trial accrual and successful completion of clinical trials, (2) partnering with the NCI to be a pilot site to grow translational research in the community, and (3) utilizing our Minority and Outreach Navigators to strengthen and further develop partnerships with community organizations.